Showing results (11-20 of 638) with videos related to

Sort By:
Pageof 64
Vox Sanguinis|January 1, 1986
Enrichment of human bone marrow aspirates for low-density mononuclear cells using a haemonetics discontinuous blood cell separatorR Raijmakers, T de Witte, E Koekman, et al.
British Journal of Haematology|March 1, 1986
The relation of exposure time and drug concentration in their effect on cloning efficiency after incubation of human bone marrow with cytosine arabinosideR Raijmakers, T de Witte, P Linssen, et al.
The Netherlands Journal of Medicine|February 1, 1990
Continuous intravenous administration of daunorubicin and cytarabine for remission induction of poor risk acute myelogenous leukaemias and myelodysplastic syndromesB M Bär, T de Witte, B E de Pauw, et al.
Seminars in Oncology|June 1, 1987
Influence of dose and duration of exposure on the cytotoxic effect of cytarabine toward human hematopoietic clonogenic cellsP Muus, C Haanen, R Raijmakers, et al.
Bone Marrow Transplantation|March 1, 1989
Anthracyclines added to the conditioning regimen for allogeneic bone marrow transplantation are associated with a slower haematopoietic recoveryN Van der Lely, T De Witte, J Raemaekers, et al.
Vox Sanguinis|January 1, 1985
Concentration of hematopoietic progenitor cells from human bone marrow by a new type of blood component separatorC G Figdor, T de Witte, R Raymakers, et al.
British Journal of Cancer|August 1, 1987
Infusion-rate independent cellular adriamycin concentrations and cytotoxicity to human bone marrow clonogenic cells (CFU-GM)R Raijmakers, P Speth, T de Witte, et al.
Transplantation|February 1, 1984
Bone marrow repopulation capacity after transplantation of lymphocyte-depleted allogeneic bone marrow using counterflow centrifugationT de Witte, R Raymakers, A Plas, et al.
Cancer|April 1, 1984
Allogeneic bone marrow transplantation in a patient with acute myeloid leukemia secondary to Hodgkin's diseaseT de Witte, H A Blacklock, H G Prentice, et al.
Experimental Hematology|May 1, 1991
Prolonged exposure to cytosine arabinoside in the presence of hematopoietic growth factors preferentially kills leukemic versus normal clonogenic cellsN Van Der Lely, T De Witte, P Muus, et al.
Pageof 64